CAS 879562-26-2: (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-methylethenyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylate
Formula:C29H28N6O5
InChI:InChI=1S/C29H28N6O5/c1-5-8-24-30-25(17(2)3)26(28(36)38-16-23-18(4)39-29(37)40-23)35(24)15-19-11-13-20(14-12-19)21-9-6-7-10-22(21)27-31-33-34-32-27/h6-7,9-14H,2,5,8,15-16H2,1,3-4H3,(H,31,32,33,34)
InChI key:InChIKey=PSFJJUXSEHXDFN-UHFFFAOYSA-N
SMILES:C(N1C(C(OCC2=C(C)OC(=O)O2)=O)=C(C(C)=C)N=C1CCC)C3=CC=C(C=C3)C4=C(C=CC=C4)C=5NN=NN5
Synonyms:- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-methylethenyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylate
- 1H-Imidazole-5-carboxylic acid, 4-(1-methylethenyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 1H-Imidazole-5-carboxylic acid, 4-(1-methylethenyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- Olmesartan medoxomil impurity I
Sort by
Found 8 products.
Olmesartan Medoxomil EP Impurity C
CAS:Formula:C29H28N6O5Color and Shape:White To Off-White SolidMolecular weight:540.584-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methylester
CAS:Formula:C29H28N6O5Purity:99%Color and Shape:SolidMolecular weight:540.5698199999998Olmesartan EP Impurity C
CAS:Olmesartan medoxomil is a prodrug that is metabolized to the active form, olmesartan, in the liver. The esters of olmesartan medoxomil are metabolized by hydrolysis and by esterases. The most common side effects of olmesartan medoxomil are headache, dizziness, fatigue, nausea and diarrhea. Olmesartan medoxomil is used for the treatment of high blood pressure in adults. This drug also has anti-inflammatory properties due to its inhibition of prostaglandin synthesis.Formula:C29H28N6O5Purity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:540.57 g/molDehydro Olmesartan Medoxomil
CAS:Controlled ProductImpurity Olmesartan EP Impurity C/ Olmesartan Impurity RNH 6373 Applications Dehydro Olmesartan Medoxomil (Olmesartan EP Impurity C) is an intermediate used in the process for purifying Olmesartan Medoxomil. References Yanagisawa, H., et al.: J. Med. Chem., 39, 323 (1996),Formula:C29H28N6O5Color and Shape:NeatMolecular weight:540.57Olmesartan medoxomil impurity C
CAS:Impurity C of Olmesartan medoxomil is a selective AT1 inhibitor with an IC50 of 66.2 μM.Formula:C29H28N6O5Color and Shape:SolidMolecular weight:540.57
![4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA00GWNE.jpg&w=3840&q=75)
